Murphy K, Zhang A, Bittel A, Chen Y
J Pers Med. 2023; 13(7).
PMID: 37511653
PMC: 10381554.
DOI: 10.3390/jpm13071040.
Fionda L, Vanoli F, Di Pasquale A, Leonardi L, Morino S, Merlonghi G
Neurol Sci. 2023; 44(11):4057-4064.
PMID: 37311950
PMC: 10570177.
DOI: 10.1007/s10072-023-06842-5.
Delourme M, Charlene C, Gerard L, Ganne B, Perrin P, Vovan C
Neurol Genet. 2023; 9(3):e200076.
PMID: 37200893
PMC: 10188231.
DOI: 10.1212/NXG.0000000000200076.
Laberthonniere C, Novoa-Del-Toro E, Delourme M, Chevalier R, Broucqsault N, Mazaleyrat K
J Cachexia Sarcopenia Muscle. 2021; 13(1):621-635.
PMID: 34859613
PMC: 8818656.
DOI: 10.1002/jcsm.12835.
Monforte M, Bortolani S, Torchia E, Cristiano L, Laschena F, Tartaglione T
J Neurol. 2021; 269(4):2055-2063.
PMID: 34486074
DOI: 10.1007/s00415-021-10786-1.
AKT Signaling Modifies the Balance between Cell Proliferation and Migration in Neural Crest Cells from Patients Affected with Bosma Arhinia and Microphthalmia Syndrome.
Laberthonniere C, Novoa-Del-Toro E, Chevalier R, Broucqsault N, Rao V, Trani J
Biomedicines. 2021; 9(7).
PMID: 34209568
PMC: 8301469.
DOI: 10.3390/biomedicines9070751.
Mental health and coping strategies in families of children and young adults with muscular dystrophies.
Tesei A, Nobile M, Colombo P, Civati F, Gandossini S, Mani E
J Neurol. 2020; 267(7):2054-2069.
PMID: 32222927
DOI: 10.1007/s00415-020-09792-6.
FSHD1 and FSHD2 form a disease continuum.
Sacconi S, Briand-Suleau A, Gros M, Baudoin C, Lemmers R, Rondeau S
Neurology. 2019; 92(19):e2273-e2285.
PMID: 30979860
PMC: 6537132.
DOI: 10.1212/WNL.0000000000007456.
Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy.
Jones T, Himeda C, Perez D, Jones P
Neuromuscul Disord. 2017; 27(3):221-238.
PMID: 28161093
PMC: 5815870.
DOI: 10.1016/j.nmd.2016.12.007.
Dnmt1 regulates the myogenic lineage specification of muscle stem cells.
Liu R, Kim K, Jung Y, Park I
Sci Rep. 2016; 6:35355.
PMID: 27752090
PMC: 5082760.
DOI: 10.1038/srep35355.
Facioscapulohumeral Dystrophy.
Wang L, Tawil R
Curr Neurol Neurosci Rep. 2016; 16(7):66.
PMID: 27215221
DOI: 10.1007/s11910-016-0667-0.
Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.
Jones T, King O, Himeda C, Homma S, Chen J, Beermann M
Clin Epigenetics. 2015; 7:37.
PMID: 25904990
PMC: 4405830.
DOI: 10.1186/s13148-015-0072-6.
Upper girdle imaging in facioscapulohumeral muscular dystrophy.
Tasca G, Monforte M, Iannaccone E, Laschena F, Ottaviani P, Leoncini E
PLoS One. 2014; 9(6):e100292.
PMID: 24932477
PMC: 4059711.
DOI: 10.1371/journal.pone.0100292.
Elderly onset of weakness in facioscapulohumeral muscular dystrophy.
Fee D
Case Rep Neurol Med. 2012; 2012:726984.
PMID: 23024867
PMC: 3457597.
DOI: 10.1155/2012/726984.
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.
Tasca G, Pescatori M, Monforte M, Mirabella M, Iannaccone E, Frusciante R
PLoS One. 2012; 7(6):e38779.
PMID: 22719944
PMC: 3374833.
DOI: 10.1371/journal.pone.0038779.
Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy.
Pastorello E, Cao M, Trevisan C
Clin Neurol Neurosurg. 2011; 114(3):230-4.
PMID: 22079131
PMC: 3314982.
DOI: 10.1016/j.clineuro.2011.10.022.
Immunodetection of human double homeobox 4.
Geng L, Tyler A, Tapscott S
Hybridoma (Larchmt). 2011; 30(2):125-30.
PMID: 21529284
PMC: 3132944.
DOI: 10.1089/hyb.2010.0094.
Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial.
Voet N, Bleijenberg G, Padberg G, van Engelen B, Geurts A
BMC Neurol. 2010; 10:56.
PMID: 20591139
PMC: 2906431.
DOI: 10.1186/1471-2377-10-56.